COVID-19 interventions: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
==Interventions==
==Interventions==


===Mechanical Ventilation===
=== Airway management ===
 
==== Non-invasive ventilation (NIV) and High Flow Nasal Oxygen ====
 
====Mechanical Ventilation====
Mechanical ventilation can be used in patients who have labored breathing and are unable to maintain adequate gaseous excange leading to hypoxemia and/or hypercapnia. Common clinical indications of mechanical ventilation include moderate to severe dyspnea, respiratory rate (RR) > 24-30/min, signs of increased breathing, accessory muscle use for breathing and abdominal paradox. It may also be used in patients who have inadequate arterial partial pressure of oxygen or critically low PaO2 (PaO2 < 70 mm Hg), hypercapnia PaCO2 > 45 mm Hg and PaO2/FiO2 < 200.
 
'''Special Considerations'''
 
In patients suffering from COVID-19, airways management can be high-risk due to aerosol-based transmission for the following reasons:
 
* Combative or agitated patient secondary to hypoxia
* Personal protective equipment may need to be removed
* Clinicians in close proximity to the patient's airway may be at risk
* Larygoscopy and intubation may become high risk secondary to aerosol generation
 
<br />

Revision as of 15:02, 19 March 2020

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 interventions

CDC on COVID-19 interventions

COVID-19 interventions in the news

Blogs on COVID-19 interventions

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 interventions

Overview

Interventions

Airway management

Non-invasive ventilation (NIV) and High Flow Nasal Oxygen

Mechanical Ventilation

Mechanical ventilation can be used in patients who have labored breathing and are unable to maintain adequate gaseous excange leading to hypoxemia and/or hypercapnia. Common clinical indications of mechanical ventilation include moderate to severe dyspnea, respiratory rate (RR) > 24-30/min, signs of increased breathing, accessory muscle use for breathing and abdominal paradox. It may also be used in patients who have inadequate arterial partial pressure of oxygen or critically low PaO2 (PaO2 < 70 mm Hg), hypercapnia PaCO2 > 45 mm Hg and PaO2/FiO2 < 200.

Special Considerations

In patients suffering from COVID-19, airways management can be high-risk due to aerosol-based transmission for the following reasons:

  • Combative or agitated patient secondary to hypoxia
  • Personal protective equipment may need to be removed
  • Clinicians in close proximity to the patient's airway may be at risk
  • Larygoscopy and intubation may become high risk secondary to aerosol generation